Pricing Log in Create free account

Evogene Ltd. (EVGN) vs Traws Pharma, Inc. (TRAW)

Evogene Ltd. and Traws Pharma, Inc. are both Biotechnology companies. Evogene Ltd. and Traws Pharma, Inc. are of similar size ($6.3M and $6.2M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against −54.7%. Traws Pharma, Inc. has the higher net margin (0.00% vs −547.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Traws Pharma, Inc. leads on 9 and Evogene Ltd. on 7.

Valuation

Metric EVGN TRAW Biotechnology median
P/E n/m n/m 8.50
P/S 2.87 2.06 9.71
P/B 0.82 3.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.43 n/m 0.64
EV/Sales (2.77) 0.30 9.21
Earnings yield (233.33%) (475.68%) (33.15%)
Free cash flow yield (226.59%) (287.29%) (25.50%)

Profitability

Metric EVGN TRAW Biotechnology median
Gross margin (67.59%) 100.00% 65.16%
Operating margin (851.42%) 0.00% 0.00%
Net margin (547.62%) 0.00% 0.00%
Free cash flow margin (650.63%) 0.00% 0.00%
Return on equity (100.03%) (319.42%) (56.36%)
Return on assets (38.31%) (117.35%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EVGN TRAW Biotechnology median
Revenue growth (TTM) (54.71%) 1,159.29% 6.02%
EPS growth (last fiscal year) 62.63% 100.76% 30.26%
Revenue growth, 5-year CAGR 29.94% 64.59% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVGN TRAW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.57 0.93 4.72
Net debt to EBITDA 1.12 0.21 0.96

Dividend

Metric EVGN TRAW Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EVGN TRAW Biotechnology median
Market cap 6.32m 6.20m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack